Clinical & Laboratory Haematology · 2000 · 123 citations · 18 references
MedicineOncologyPathologyCancer ImmunologyImmunopathologyTumor ImmunologyLymphoid NeoplasmsLymphoid TissueLymphoid TumorsNatural Killer Cell BiologyDisease-free Survival AnalysisDisease-free Survival AssessmentNasal-associated Lymphoid TissueNatural Killer T-cell LymphomaNatural Killer-cell LymphomaPrognostic Factors AnalysisPrognostic IndicesRevised International Prognostic Scoring System
Angiocentric T cell/natural killer (NK) nasal lymphoma remains a rare clinical presentation in North America and Europe but is more common in Asia and Latin America. We have reviewed 108 cases of angiocentric T/NK cell lymphoma of the nasal cavity with a view to establishing prognostic factors. Most patients were high or high intermediate clinical risk and had additional poor prognostic factors such as bulky disease, high levels of beta 2 microglobulin, advanced stage and multiple extranodal involvement. At 8 years, overall survival was 82%, 90% and 84% for low-intermediate, high-intermediate and high clinical, respectively. Disease free survival was very similar: 79%, 83% and 80%, respectively. Multivariate analysis did not identify any factor influencing overall survival and disease-free survival. There was no evidence that the international prognostic index (IPI) was applicable in these patients and it appears that angiocentric T/NK cell lymphoma is an independent prognostic factor itself.
18
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
New England Journal of Medicine · 1993 · 5K citations · Full text
Medicine, Oncology, Chemotherapy +15
A predictive model for aggressive non-Hodgkin's lymphoma
Margaret A. Shipp, David P. Harrington, J R Anderson et al. · 1993 · 3.5K citations
Medicine, Oncology, Chemotherapy +15